1. "Gregory Riely"
Formats
  1. Journal Article (271)
  2. Meeting Abstract (249)
  3. Book Section (16)
  4. Guidelines (11)
  5. Conference Paper (4)
  6. Review (2)
  7. Book Whole (1)
  8. Correspondence (1)
  9. Editorial (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (557)
  2. Solid Tumor Oncology Division (557)
  3. Thoracic Oncology (557)
  4. GSK Faculty (224)
  5. Human Oncology and Pathogenesis Program (203)
  6. Tow Center for Developmental Oncology (TCDO) (178)

More Groups

People
  1. Gregory Riely (557)
  2. Mark Kris (211)
  3. Marc Ladanyi (175)
  4. Helena Yu (97)
  5. Maria Arcila (81)
  6. Vincent Miller (79)

More People

Years
  1. 2023 (31)
  2. 2022 (39)
  3. 2021 (41)
  4. 2020 (29)
  5. 2019 (38)
  6. 2018 (37)

More Years

Publications
  1. Journal of Clinical Oncology (149)
  2. Journal of Thoracic Oncology (106)
  3. Clinical Cancer Research (43)
  4. Annals of Oncology (29)
  5. Journal of the National Comprehensive Cancer Network (21)
  6. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (163)
  2. Elsevier Inc. (128)
  3. American Association for Cancer Research (69)
  4. Oxford University Press (33)
  5. Elsevier Science, Inc. (23)
  6. Harborside Press (21)

More Publishers

Results (557)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for patients with pleural metastases from thymic malignancies
    Meeting Abstract

    Rimner, A.; Huang, J.; Pagano, A.; Ginsberg, M. S.; Chang, J. C.; Riely, G. J.; Simone, C. B.; Gomez, D. R.; Shepherd, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)
    Meeting Abstract

    Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF (V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study
    Meeting Abstract

    Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A. S.; Johnson, M. L.; Gelsomino, F.; Esper, R. M.; Nadal, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Big data in oncology: Challenges and solutions
    Meeting Abstract

    Shah, N. J.; Bahadur, N.; Niederhausern, A.; Insinga, A.; Shah, I.; West, G.; Ahmad, H.; Martin, S.; Watson, A.; Nichols, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Large-scale clinicogenomic models of solid tumor CNS metastasis
    Meeting Abstract

    Jee, J.; Luthra, A.; Fong, C.; Pichotta, K.; Tran, T.; Altoe, M.; Miller, A.; Shen, R.; Berger, M. F.; Sanchez-Vega, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR-mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study
    Meeting Abstract

    Yang, J. C. H.; Lee, D. H.; Lee, J. S.; Fan, Y.; de Marinis, F.; Okamoto, I.; Inoue, T.; Cid, J. R. R.; Zhang, L.; Yang, C. T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO Living Guideline, version 2023.2
    Guidelines

    Owen, D. H.; Singh, N.; Ismaila, N.; Masters, G.; Riely, G. J.; Robinson, A. G.; Schneider, B. J.; Jaiyesimi, I. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save